Safety and Efficacy of Fluoroscopy-free Technique During Retrograde Intrarenal Surgery for Renal Stones
NCT ID: NCT05269108
Last Updated: 2023-04-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
520 participants
INTERVENTIONAL
2022-02-25
2024-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Flexible Mini Percutaneous Nephrolithotomy Vs Retrograde Intra-renal Surgery
NCT06249100
Prospective Assessment of Procedure-Related and Patient-Reported Outcomes After Retrograde Intrarenal Surgery (RIRS) for Renal Calculi Less Than 20 mm
NCT03719456
Sheathless, Traditional, and Suction Access Sheath RIRS for Renal Stones ≤2 cm
NCT07289230
RIRS for Treatment of Stones in Congenital Anomalous Kidneys
NCT05240170
Mini-PNL, RIRS, and ESWL for Treatment of Medium-Sized, High-Density, Non-Lower Pole, Renal Stones
NCT04856722
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
In an effort to decrease radiation exposure, several studies were conducted to evaluate the possibility of performing RIRS under direct visualization without fluoroscopy. Most studies concluded that fluoroscopy-free RIRS is a feasible, effective, and safe technique. The reported stone-free rate ranged from 83.8% to 95.7%. No major complications were observed.
Despite the reported high safety and efficacy of the fluoroscopy-free RIRS technique, most of the studies were retrospective and included only uncomplicated cases, and none of the studies address its results against control.
In the present study, the investigators will prospectively evaluate the efficacy and safety of fluoroscopy-free RIRS for renal stones in comparison with fluoroscopy-guided technique as standard control. The study will include all patients with renal stones amenable to RIRS. The investigators expected that the fluoroscopy-free technique can deal with large stones and complex situations with high safety and success rate. The study hypothesis is that "the fluoroscopy-free technique has efficacy and safety similar to the fluoroscopy-guided technique".
The investigators also aim to determine the patients and surgical characteristics impacting the need for fluoroscopy. The intra-operative fluoroscopy imaging is expected to be necessary during RIRS, especially in complicated cases. In the fluoroscopic-free group, the fluoroscopic equipment will be available in the operating room and will be used if needed.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Fluoroscopy-free RIRS
Patients will be treated by RIRS without fluoroscopy
Fluoroscopy-free RIRS
RIRS for renal stone under direct visualization, without fluoroscopy
Standard RIRS
Standard RIRS under fluoroscopy-guidance will be performed
Standard RIRS
RIRS for renal stone under fluoroscopy-guidance
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Fluoroscopy-free RIRS
RIRS for renal stone under direct visualization, without fluoroscopy
Standard RIRS
RIRS for renal stone under fluoroscopy-guidance
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Stone size: ≥10 mm.
Exclusion Criteria
* Pregnant women.
* Morbid obesity.
* Uncorrectable coagulation disorders.
* Active urinary tract infection (UTI).
* Stone in a calyceal diverticulum.
* Urinary tract obstruction distal to the stone.
* Concomitant pathology that needs intervention in the same setting.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Al-Azhar University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Abul-fotouh Ahmed
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Abul-fotouh Ahmed, MD
Role: PRINCIPAL_INVESTIGATOR
Al-Azhar University Hospitals, Cairo, Egypt
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Urology Department, Al-Azhar University Hospital
Cairo, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Uro_Azhar_2_022
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.